272 related articles for article (PubMed ID: 17942703)
1. Activated vitamin D attenuates left ventricular abnormalities induced by dietary sodium in Dahl salt-sensitive animals.
Bodyak N; Ayus JC; Achinger S; Shivalingappa V; Ke Q; Chen YS; Rigor DL; Stillman I; Tamez H; Kroeger PE; Wu-Wong RR; Karumanchi SA; Thadhani R; Kang PM
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):16810-5. PubMed ID: 17942703
[TBL] [Abstract][Full Text] [Related]
2. Doxercalciferol, a pro-hormone of vitamin D, prevents the development of cardiac hypertrophy in rats.
Choi JH; Ke Q; Bae S; Lee JY; Kim YJ; Kim UK; Arbeeny C; Thadhani R; Kang PM
J Card Fail; 2011 Dec; 17(12):1051-8. PubMed ID: 22123370
[TBL] [Abstract][Full Text] [Related]
3. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
Sakata Y; Masuyama T; Yamamoto K; Nishikawa N; Yamamoto H; Kondo H; Ono K; Otsu K; Kuzuya T; Miwa T; Takeda H; Miyamoto E; Hori M
Circulation; 2000 Oct; 102(18):2269-75. PubMed ID: 11056104
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen gas improves left ventricular hypertrophy in Dahl rat of salt-sensitive hypertension.
Matsuoka H; Miyata S; Okumura N; Watanabe T; Hashimoto K; Nagahara M; Kato K; Sobue S; Takeda K; Ichihara M; Iwamoto T; Noda A
Clin Exp Hypertens; 2019; 41(4):307-311. PubMed ID: 29902079
[TBL] [Abstract][Full Text] [Related]
5. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
[TBL] [Abstract][Full Text] [Related]
6. Xanthine Oxidase Inhibitor, Febuxostat Ameliorates the High Salt Intake-Induced Cardiac Hypertrophy and Fibrosis in Dahl Salt-Sensitive Rats.
Namai-Takahashi A; Sakuyama A; Nakamura T; Miura T; Takahashi J; Kurosawa R; Kohzuki M; Ito O
Am J Hypertens; 2019 Jan; 32(1):26-33. PubMed ID: 30277494
[TBL] [Abstract][Full Text] [Related]
7. Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction.
Klotz S; Hay I; Zhang G; Maurer M; Wang J; Burkhoff D
Hypertension; 2006 May; 47(5):901-11. PubMed ID: 16585423
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats.
Chi L; Belardinelli L; Zeng A; Hirakawa R; Rajamani S; Ling H; Dhalla AK
Am J Physiol Heart Circ Physiol; 2016 May; 310(10):H1313-20. PubMed ID: 26993228
[TBL] [Abstract][Full Text] [Related]
9. Reduction of development of left ventricular hypertrophy in salt-loaded Dahl salt-sensitive rats by angiotensin II receptor inhibition.
de Simone G; Devereux RB; Camargo MJ; Wallerson DC; Sealey JE; Laragh JH
Am J Hypertens; 1996 Mar; 9(3):216-22. PubMed ID: 8695019
[TBL] [Abstract][Full Text] [Related]
10. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
[TBL] [Abstract][Full Text] [Related]
11. Local neurohumoral regulation in the transition to isolated diastolic heart failure in hypertensive heart disease: absence of AT1 receptor downregulation and 'overdrive' of the endothelin system.
Yamamoto K; Masuyama T; Sakata Y; Doi R; Ono K; Mano T; Kondo H; Kuzuya T; Miwa T; Hori M
Cardiovasc Res; 2000 Jun; 46(3):421-32. PubMed ID: 10912453
[TBL] [Abstract][Full Text] [Related]
12. Pravastatin increases survival and suppresses an increase in myocardial matrix metalloproteinase activity in a rat model of heart failure.
Ichihara S; Noda A; Nagata K; Obata K; Xu J; Ichihara G; Oikawa S; Kawanishi S; Yamada Y; Yokota M
Cardiovasc Res; 2006 Feb; 69(3):726-35. PubMed ID: 16165109
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular effects of the combination of levosimendan and valsartan in hypertensive Dahl/Rapp rats.
Biala A; Finckenberg P; Korpi A; Loytainen M; Martonen E; Levijoki J; Mervaala E
J Physiol Pharmacol; 2011 Jun; 62(3):275-85. PubMed ID: 21893687
[TBL] [Abstract][Full Text] [Related]
14. Congenic expression of tissue inhibitor of metalloproteinase in Dahl-salt sensitive hypertensive rats is associated with reduced LV hypertrophy.
Rodriguez WE; Tyagi N; Deng AY; Adeagbo A; Joshua IG; Tyagi SC
Arch Physiol Biochem; 2008 Dec; 114(5):340-8. PubMed ID: 19003589
[TBL] [Abstract][Full Text] [Related]
15. Endothelin-A receptor blockade prevents left ventricular hypertrophy and dysfunction in salt-sensitive experimental hypertension.
Rothermund L; Vetter R; Dieterich M; Kossmehl P; Gögebakan O; Yagil C; Yagil Y; Kreutz R
Circulation; 2002 Oct; 106(18):2305-8. PubMed ID: 12403658
[TBL] [Abstract][Full Text] [Related]
16. Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor.
Bianciotti LG; de Bold AJ
Am J Physiol Heart Circ Physiol; 2002 Mar; 282(3):H1127-34. PubMed ID: 11834512
[TBL] [Abstract][Full Text] [Related]
17. Waon therapy attenuates cardiac hypertrophy and promotes myocardial capillary growth in hypertensive rats: a comparative study with fluvastatin.
Ihori H; Nozawa T; Sobajima M; Shida T; Fukui Y; Fujii N; Inoue H
Heart Vessels; 2016 Aug; 31(8):1361-9. PubMed ID: 26686369
[TBL] [Abstract][Full Text] [Related]
18. Cardiac hypertrophy and cardiac renin-angiotensin system in Dahl rats on high salt intake.
Zhao X; White R; Van Huysse J; Leenen FH
J Hypertens; 2000 Sep; 18(9):1319-26. PubMed ID: 10994763
[TBL] [Abstract][Full Text] [Related]
19. Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats.
Louhelainen M; Vahtola E; Kaheinen P; Leskinen H; Merasto S; Kytö V; Finckenberg P; Colucci WS; Levijoki J; Pollesello P; Haikala H; Mervaala EM
Br J Pharmacol; 2007 Apr; 150(7):851-61. PubMed ID: 17325658
[TBL] [Abstract][Full Text] [Related]
20. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
